Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits
Year: 1997
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm960871c
Authors: Lawrence J. MacPherson, Erol K. Bayburt, Michael P. Capparelli, Brian J. Carroll, Robert Goldstein, Michael R. Justice, Lijuan Zhu, Shou-ih Hu, Richard A. Melton, Lynn Fryer, Ron L. Goldberg, John R. Doughty, Salvatore Spirito, Vincent Blancuzzi, Doug Wilson, Elizabeth M. O'Byrne, Vishwas Ganu, David T. Parker
Institution: Novartis (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2115211598
